Transcriptomics

Dataset Information

240

Transcription profling by array of human SCLC cell lines following radiation treatment


ABSTRACT: Radiotherapy has a critical role in the treatment of small cell lung cancer (SCLC). Effectiveness of radiation in SCLC remains limited as resistance results from defects in apoptosis. In the current study, we investigated whether using a Bcl-2/Bcl-XL inhibitor S44563 can enhance radiosensitivity of SCLC cells in vitro and in vivo. In vitro studies confirmed that S44563 induce apoptosis in SCLC cells by inducing hallmarks of apoptosis (cleaved caspase-3, sub-G1 fraction induction and induction of the mitochondrial caspase activation pathway). S44563 markedly enhanced sensitivity of H146 cells and H69 cells to radiation in clonogenic assay. In addition, the combination S44563 and cisplatin-based chemo-radiation showed a dramatic tumor growth delay and increased overall survival in mouse xenograft models. In vitro experiments demonstrated a greater induction of apoptosis (sub-G1 fraction and cleaved caspase-3) with the combination as well as in vivo caspase-3 immunostaining. This positive interaction between S44563 and radiation was greater when S44563 was given after the completion of the radiation, which may be explained by the radiation-induced over expression of anti-apoptotic proteins (Bcl-2 and Bcl-XL) through the NF-?B pathway activation. Taken together, these data underline the critical role of sequence administration of targeted therapies with conventional therapies. SCLC cells which survive to IR highly rely on the induction of anti apoptotic proteins in part through NF- ?B activation for their survival yielding to the concept of 'contextual oncogene addiction' to the Bcl-2/Bcl-XL pathway providing rational for targeting survival pathways to potentiate IR. For transcriptome analysis, 106 cells were seeded in T25 flasks, allowed to growth for 24 h, and then left untreated or treated with 2 Gy radiation. After 24 hours, cells were harvested, lysed for the extraction of RNA, and processed to analyze gene expression.The design of this study consists to 6 hybridizations in dual color with Agilent Human Genome 4x44K (design 014850). The reference is always the untreated condition.

ORGANISM(S): Homo sapiens  

DISEASE(S): Small Cell Lung Cancer

SUBMITTER: Philippe DESSEN  

PROVIDER: E-MTAB-966 | ArrayExpress | 2013-02-01

REPOSITORIES: ArrayExpress

altmetric image

Publications

Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.

Loriot Y Y   Mordant P P   Dugue D D   Geneste O O   Gombos A A   Opolon P P   Guegan J J   Perfettini J-L JL   Pierre A A   Berthier L K LK   Kroemer G G   Soria J C JC   Depil S S   Deutsch E E  

Cell death & disease 20140918


Radiotherapy has a critical role in the treatment of small-cell lung cancer (SCLC). The effectiveness of radiation in SCLC remains limited as resistance results from defects in apoptosis. In the current study, we investigated whether using the Bcl-2/Bcl-XL inhibitor S44563 can enhance radiosensitivity of SCLC cells in vitro and in vivo. In vitro studies confirmed that S44563 caused SCLC cells to acquire hallmarks of apoptosis. S44563 markedly enhanced the sensitivity of SCLC cells to radiation,  ...[more]

Similar Datasets

2015-09-15 | E-MTAB-3820 | ArrayExpress
2012-03-02 | E-MTAB-1013 | ArrayExpress
2013-12-11 | E-MTAB-1132 | ArrayExpress
2013-08-01 | E-MTAB-949 | ArrayExpress
2014-05-01 | E-MTAB-1742 | ArrayExpress
2013-09-03 | E-MTAB-1269 | ArrayExpress
2013-06-30 | E-MTAB-1221 | ArrayExpress
2010-12-31 | E-TABM-873 | ArrayExpress
2013-08-13 | E-MTAB-993 | ArrayExpress
2009-09-14 | E-TABM-640 | ArrayExpress